Browsing Tag
Lunit
7 posts
Why Lunit’s AACR 2026 showcase could reshape how investors value AI-driven precision oncology platforms like KRX: 328130
Lunit’s AACR 2026 studies reveal how its cancer AI platform is moving beyond pathology into biomarker strategy. Read what this means for KRX: 328130.
Lunit submits FDA filing for AI mammography model: What’s next for U.S. breast cancer screening?
Find out how Lunit’s FDA-bound artificial intelligence risk model could change breast cancer screening and prevention in the United States. Read the full story.
What makes SimonMed’s partnership with Lunit a turning point in clinical imaging?
SimonMed Imaging partners with Lunit to launch scalable, fine-tuned AI for chest X-ray reporting. Explore how this foundation model could change radiology forever.
How Lunit and CellCarta plan to speed up cancer drug trials with AI-driven pathology
Lunit and CellCarta are bringing AI pathology into clinical trials, reshaping biomarker strategies and accelerating precision oncology worldwide.
AI shake-up in cancer care: Can Agilent and Lunit redefine biomarker testing for investors?
Agilent Technologies and Lunit partner on AI companion diagnostics, aiming to transform biomarker testing and boost investor sentiment in precision medicine.
Lunit acquires Volpara Health Technologies to advance AI in cancer diagnostics
Lunit, a leader in AI-powered solutions for cancer diagnostics and therapeutics, has completed its acquisition of Volpara Health…
Lunit announces strategic partnerships to advance AI in cancer diagnostics across Europe
Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in…